reference/34172013

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/34172013

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase I\|Journal Article\|Research Support, Non-U.S. Gov't
endingPage	76
issn	0270-9139
issueIdentifier	1
pageRange	65-76
publicationName	Hepatology (Baltimore, Md.)
startingPage	65
bibliographicCitation	Zhou J, Sun Y, Zhang W, Yuan J, Peng Z, Wang W, Gong J, Yang L, Cao Y, Zhao H, Chen C, Wang W, Shen L, Zhou A. Phase Ib study of anlotinib combined with TQB2450 in pretreated advanced biliary tract cancer and biomarker analysis. Hepatology. 2023 Jan 01;77(1):65–76. PMID: 35491432; PMCID: PMC9970018.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_82be981c73007771aa61ef9bcb463c4f http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3ad9709562fb30756083741043f29d23 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_92d63a79e28eb1f95c5e0f944d42a2b8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0002-6617-6653 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e2099642ccadc286263e3629bfb747c4 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_4ec353310d5296e5c01bf6bcb23cf57a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f6115186ad07173549015ee35c7e4cf0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2ffc8b504e95bda7f12c2fa7617055f0 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_3a16a05a4a684b9fa51e1ce33bbd9945 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e0f3201eba23a57031af7aa67bded6a6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2cad5410537ecf4ac862d93d4d525467 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f749cfdca0d90dd1b6d4e4932dc98ecc http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7ab1807b0cec8e40a43c90104c5d89bf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_16c0030bdf4c023df3410809cfda93c5
date	2022-08-18-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/35491432 https://pubmed.ncbi.nlm.nih.gov/PMC9970018 https://doi.org/10.1002/hep.32548
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/4093 https://portal.issn.org/resource/ISSN/0270-9139
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Phase Ib study of anlotinib combined with TQB2450 in pretreated advanced biliary tract cancer and biomarker analysis
discusses	http://id.nlm.nih.gov/mesh/M0024891 http://id.nlm.nih.gov/mesh/M0023752 http://id.nlm.nih.gov/mesh/M000675754 http://id.nlm.nih.gov/mesh/M000639485 http://id.nlm.nih.gov/mesh/M0001357 http://id.nlm.nih.gov/mesh/M0011238
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D001661Q000473 http://id.nlm.nih.gov/mesh/D001661Q000235 http://id.nlm.nih.gov/mesh/D016283 http://id.nlm.nih.gov/mesh/D001661Q000188
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000911Q000627 http://id.nlm.nih.gov/mesh/D007211Q000009 http://id.nlm.nih.gov/mesh/D000082082Q000627 http://id.nlm.nih.gov/mesh/D015415
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_83152927692cdd03d2f5aabc1971646c http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_404b2fd0b803c81a7b906b71315091dd http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7039 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8102 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID25017411 http://rdf.ncbi.nlm.nih.gov/pubchem/protein/EC_2.6.1.1 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8a65ae2c3e323ad41efdc6b71be9712d http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_aeebd1980c6662678028fc899ba441eb

Total number of triples: 56.